menu
    • menu

    Company profile for Cardiosense

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cardiosense is building a digital biomarker platform that leverages novel, multi-sensor devices and proprietary algorithms to detect early signs of disease and guide personalized therapy.Built on over a decade of research, our team has developed an advanced signal processing pipeline to identify pre-symptomatic markers of cardiac disease.Introducing an end-to-end patient monitoring and sensor analytics ecosystem.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CardiosenseUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 N Aberdeen St Suite 900 Chicago, IL 60642
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cardiosense.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cardiosense/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cardiosenseinc?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cardiosense Validates AI PCWP Tool In Seismic-HF I Analysis
    Cardiosense Validates AI PCWP Tool In Seismic-HF I Analysis

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106217591/en/Cardiosense-Presents-New-Analysis-of-the-SEISMIC-HF-I-Study-Validating-its-AI-Algorithm-for-Noninvasive-PCWP-Assessment-at-the-American-Heart-Associations-2025-Scientific-Sessions

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    Cardiosense Unveils AI-Enabled Heart Failure Volume Assessment
    Cardiosense Unveils AI-Enabled Heart Failure Volume Assessment

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028127555/en/Cardiosense-Presents-New-Clinical-Analysis-of-SEISMIC-HF-I-Data-on-AI-Enabled-Volume-Assessment-in-Heart-Failure-at-the-Transcatheter-Cardiovascular-Therapeutics-TCT-2025-Scientific-Symposium

    BUSINESSWIRE
    28 Oct 2025
    Share Share
    Cardiosense Names Eric CEO for AI Cardiac Care Advancement
    Cardiosense Names Eric CEO for AI Cardiac Care Advancement

    18 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250918815054/en/Cardiosense-Appoints-Eric-Meizlish-as-CEO-to-Advance-AI-Enabled-Cardiac-Care

    BUSINESSWIRE
    18 Sep 2025
    Share Share
    Cardiosense Gets FDA 510(k) Clearance for Cardiac Monitor Device
    Cardiosense Gets FDA 510(k) Clearance for Cardiac Monitor Device

    30 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250730737949/en/Cardiosense-Receives-FDA-510k-Clearance-for-the-CardioTag-Device-Paving-the-Way-for-Advanced-Cardiac-Function-Monitoring

    BUSINESSWIRE
    30 Jul 2025
    Share Share
    Cardiosense Begins HF Study for AI Algorithm Validation
    Cardiosense Begins HF Study for AI Algorithm Validation

    28 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250528803782/en/Cardiosense-Launches-Nationwide-SEISMIC-HF-II-Study-to-Validate-Its-AI-Algorithm-for-Non-Invasive-Heart-Failure-Management

    BUSINESSWIRE
    28 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search